Driehaus Capital Management
MAZE icon

Driehaus Capital Management’s Maze Therapeutics MAZE Stock Holding History

Driehaus Capital Management’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.5M Buy
954,886
+318,724
+50% +$8.35M 0.17% 186
2026
Q1 		$19M Buy
636,162
+258,147
+68% +$11.4M 0.14% 211
2025
Q4 		$15.7M Hold
378,015
– – 0.11% 229
2025
Q3 		$9.8M Buy
378,015
+184,615
+95% +$3.12M 0.07% 280
2025
Q2 		$2.37M Buy
193,400
+61,285
+46% +$638K 0.02% 326
2025
Q1 		$1.45M Buy
+132,115
New +$1.59M 0.01% 333

Other funds holding MAZE

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TRV GP IV
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
Arch Venture Management
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AH Capital Management
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Driehaus Capital Management's MAZE Position: Q2 2026 in Review

Driehaus Capital Management increased its Maze Therapeutics (MAZE) stake by 50% in Q2 2026, buying an estimated $8.35M and bringing the position to 954,886 shares worth $28.5M. The position accounts for 0.17% of the portfolio, ranked #186.

Driehaus Capital Management first reported a position in MAZE in Q1 2025 and has held it in 6 quarters since. 161 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Driehaus Capital Management held 954,886 shares of Maze Therapeutics worth $28.5M as of Q2 2026.
  • Driehaus Capital Management bought 318,724 Maze Therapeutics shares in Q2 2026, an estimated $8.35M.
  • Maze Therapeutics made up 0.17% of Driehaus Capital Management's portfolio in Q2 2026, its #186 holding.
  • Driehaus Capital Management first reported a position in Maze Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 161 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.